The bill establishes a health equity program and fund under the Department of Health and Human Services (HHS) aimed at improving menstrual and post-menstrual health. It provides for reimbursement of costs associated with covered services and treatments related to these health conditions that are not covered by third-party payors. The program will be promoted statewide, with administrative costs capped at 4% of the appropriated funds. HHS is tasked with adopting rules to specify the types of covered services, which may include hormone treatments, urinary tract treatments, and other related therapies, based on evidence from health experts.

Additionally, the bill creates a health equity program fund that will include appropriations from the general assembly and other available moneys. Funds remaining at the end of each fiscal year will not revert to the general fund but will remain in the health equity program fund. The bill also mandates that HHS submit an annual report to the governor and the general assembly detailing the program's status, including the fund balance, number of participating providers, and reimbursement details. The bill defines "genitourinary agents" and "period products" to clarify the scope of the program.